Depletion of MAP2 has been associated with a Lewy body variant of Alzheimer’s disease [16], whereas colocalization of MAP2 with α-synuclein in Lewy bodies was shown in Parkinson’s disease [17]. This evidence concerns the gene MAP2 and Parkinson disease.